These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Conflicts of interest within the French regulatory agency: more progress needed. Prescrire Int; 2010 Aug; 19(108):186-8. PubMed ID: 20939461 [TBL] [Abstract][Full Text] [Related]
5. The promise and peril of direct-to-consumer prescription drug promotion on the Internet. Hall TS DePaul J Health Care Law; 2003; 7(1):1-41. PubMed ID: 15468476 [No Abstract] [Full Text] [Related]
6. What market values are doing to medicine. Relman AS Atlantic; 1992 Mar; 269(3):98-102, 105-106. PubMed ID: 11651349 [No Abstract] [Full Text] [Related]
7. Pitching doctors. Wilkes MS; Shuchman M N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264 [No Abstract] [Full Text] [Related]
8. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey. Rutledge P; Crookes D; McKinstry B; Maxwell SR Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982 [TBL] [Abstract][Full Text] [Related]
9. Combination drugs--hype, harm, and hope. Podolsky SH; Greene JA N Engl J Med; 2011 Aug; 365(6):488-91. PubMed ID: 21830965 [No Abstract] [Full Text] [Related]
10. Personal effects. Can emotive marketing through relationships influence rational doctors' prescriptions? Srivastava RK Mark Health Serv; 2007; 27(4):29-32. PubMed ID: 18186452 [No Abstract] [Full Text] [Related]
11. Recognising expertise would help to attract independent experts. Prescrire Int; 2010 Aug; 19(108):187. PubMed ID: 20939462 [No Abstract] [Full Text] [Related]
12. Japan takes its medicine. Hadfield P New Sci; 1996 Jun; 150(2032):14-5. PubMed ID: 11656542 [No Abstract] [Full Text] [Related]
15. FDA issues concerning conflicts of interest. Kurt TL IRB; 1990; 12(5):6-9. PubMed ID: 11654003 [No Abstract] [Full Text] [Related]
16. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate. Dorfman HL; Quinn VM; Brophy EA Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765 [No Abstract] [Full Text] [Related]
17. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform. Maatz CT High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962 [No Abstract] [Full Text] [Related]
18. The case for preemption of prescription drug failure-to-warn claims. Kim CH Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969 [No Abstract] [Full Text] [Related]
19. [Doctors and the drug industry]. Gudmundsson S Laeknabladid; 2005 Mar; 91(3):234. PubMed ID: 16155323 [No Abstract] [Full Text] [Related]